Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company®,
today announced that South Nassau Communities Hospital (South
Nassau), a 435-bed teaching hospital located in Oceanside, NY, has
selected the company’s Sunrise Enterprise™ suite of integrated
clinical solutions. South Nassau’s technology initiative, which
includes Eclipsys’ leading computerized physician order entry
(CPOE) solution, will support creating a unified electronic system
throughout departments to transform care delivery processes for
safer care, greater efficiency and improved outcomes. The
investment in advanced technology also will support South Nassau in
its goal to meet the recently finalized “Meaningful Use”
requirements of the American Recovery and Reinvestment Act (ARRA)
of 2009 to qualify for stimulus funds.
South Nassau’s plans call for deployment of Eclipsys’ CPOE
solution to support evidence-based practices and clinical decision
making, along with the company’s integrated pharmacy solution,
Sunrise Pharmacy™. Working in concert via a single database, the
solution enables integrated handoffs between clinicians and
pharmacists resulting in fewer errors and accelerated time to
medication treatment. Deployment of Eclipsys’ clinical
documentation solution, e-prescribing and orders reconciliation
solutions will contribute to further clinical efficiency,
medication safety and care team collaboration. In combination,
these new solutions will create a single electronic health record
(EHR) across care venues to improve care team efficiency and
clinical decision making.
“This significant technology initiative continues our unwavering
commitment to provide the highest quality healthcare services to
our community,” said John Mertz, chief information officer at South
Nassau. “We believe that technology will continue to exponentially
replace healthcare’s dependence on paper-based, manual processes.
Eclipsys’ proven track record in helping clients achieve deep
physician adoption of its systems gave us confidence we chose the
right technology partner as an essential step toward providing
truly excellent patient care and to meet the expected meaningful
use requirements by specified timelines.”
Partnering with a Leader in CPOE to Meet Meaningful
Use
The Center for Medicare and Medicaid Services’(CMS) final rule
on ‘meaningful use’ of an EHR includes the requirement that at
least 30 percent of a hospital’s patients with a medication order
must have that order entered through a CPOE solution. In Stage 2 of
‘meaningful use,’ scheduled to occur in 2013, the percentage of
CPOE medication orders requirement doubles to 60 percent. Eclipsys
estimates its U.S. client base has achieved on average a 70-percent
CPOE adoption rate. In fact, according to the 2010 CPOE study
entitled “CPOE: Traffic Jams on the Road to Meaningful Use” issued
by KLAS Enterprises, LLC, Eclipsys is recognized as a leader in
CPOE and among the most ‘meaningful use-ready’ vendors. In the same
report, Eclipsys was recognized as having the greatest percentage
of its client base live with CPOE, highest customer satisfaction
with CPOE, and greatest percentage of significant or deep physician
CPOE users in recently live hospitals.
Additional Key Solutions and Services for ‘Meaningful
Use’
With a transition to a comprehensive electronic system, South
Nassau also selected Eclipsys’ Sunrise Clinical Analytics™ solution
to leverage the rich healthcare data flowing through its EHR to
support optimizing care processes. Near real-time analytics and
reporting capabilities will support improved care team decisions,
as well as patient safety and other quality initiatives. In
addition, Eclipsys’ Sunrise Patient Portal™ will provide South
Nassau patients with self-service functionality, such as internet
access to updated health information and the ability to schedule
doctor appointments. This level of patient connectivity and access
to information is another facet providers must demonstrate to meet
ARRA meaningful use requirements.
South Nassau plans to utilize Eclipsys’ “speed to value”
implementation approach, accelerating the activation to help meet
the specified ARRA timeline requirements and maximize stimulus
payment opportunities. The approach leverages Eclipsys’ rich client
knowledge to provide more than 1,000 suggested design decisions to
help reduce deployment cycle time and enable clients to focus on
value-added activities during the implementation. South Nassau will
also use Eclipsys’ remote hosting services to support managing its
new technology infrastructure, delivering powerful CPU processing,
fast storage and dedicated point-to-point communications.
“We are very pleased that South Nassau Communities Hospital
chose to partner with Eclipsys as they pursue their goal of
promoting the best quality of care for their community while
leveraging the opportunity to receive federal stimulus dollars,”
said Jay Deady, Eclipsys’ executive vice president of Client
Solutions. “Eclipsys understands that physician adoption of
technology is the key to improving patient outcomes and reducing
costs, which is the ultimate goal behind ARRA. In combination with
our proven “speed to value” implementation methodology, we are
confident that South Nassau will quickly and effectively make great
strides in its ARRA and clinical quality goals.”
About South Nassau Communities Hospital
South Nassau Communities Hospital is one of the region’s largest
hospitals, with 435 beds, more than 875 physicians and 2,800
employees. Located in Oceanside, NY, the hospital is an acute-care,
not-for-profit teaching hospital that provides state-of-the-art
care in cardiac, oncologic, orthopedic, bariatric, pain management,
mental health and emergency services. In addition to its extensive
outpatient specialty centers, South Nassau provides emergency and
elective angioplasty and is the only hospital on Long Island with
the Novalis Tx and Gamma Knife radiosurgery technologies. South
Nassau is a designated Stroke Center by the New York State
Department of Health and Comprehensive Community Cancer Center by
the American College of Surgeons and is recognized as a Bariatric
Surgery Center of Excellence by the American Society for Metabolic
and Bariatric Surgery. For more information, see
www.southnassau.org.
About the CPOE: Traffic Jams on the Road to Meaningful Use
Report
The “CPOE: Traffic Jams on the Road to Meaningful Use” report
was compiled data from healthcare executives, managers and
clinicians. The study provided detailed information on several
criteria including current CPOE usage at healthcare organizations,
product capabilities and vendor performance.
About KLAS
KLAS is a research firm specializing in monitoring and reporting
the performance of healthcare vendors. KLAS' mission is to improve
delivery, by independently measuring vendor performance for the
benefit of our healthcare provider partners, consultants,
investors, and vendors. Working together with executives from over
4,500 hospitals and over 2,500 clinics, KLAS delivers timely
reports, trends, and statistics, which provide a solid overview of
vendor performance in the industry. KLAS measures performance of
software, professional services, and medical equipment vendors. For
more information, go to www.KLASresearch.com, or email
marketing@KLASresearch.com, or call 1-800-920-4109 to speak with a
KLAS representative.
About Eclipsys
Eclipsys is a leading provider of advanced integrated clinical,
revenue cycle and performance management software, clinical content
and professional services that help healthcare organizations
improve clinical, financial and operational outcomes. For more
information, see www.eclipsys.com or email info@eclipsys.com.
Statements in this news release concerning the implementation of
and features and benefits provided by Eclipsys software, including
clinical outcomes, safety, and efficiency, ARRA qualification,
physician adoption, evidence-based content and services are
forward-looking statements and actual results may differ from those
projected due to a variety of risks and uncertainties.
Implementation and client-specific configuration of Eclipsys
software can be complex and time-consuming. Results depend upon a
variety of factors and can vary by client. Each client’s
circumstances are unique and may include unforeseen issues that
make it more difficult than anticipated to implement or derive
benefit from Eclipsys software or services. The success and
timeliness of the company’s services will depend at least in part
upon client involvement, which can be difficult to control.
Eclipsys is required to meet specified performance standards, and
the contract can be terminated or its scope reduced under certain
circumstances. ARRA qualification requires compliance with
standards that are still evolving, and satisfaction of those
standards may be delayed. More information about company risks is
available in recent Form 10-Q and 10-K filings made by Eclipsys
from time to time with the Securities and Exchange Commission.
Special attention is directed to the portions of those documents
entitled “Risk Factors” and “Management’s Discussion and Analysis
of Financial Condition and Results of Operations.” Eclipsys, The
Outcomes Company, Sunrise Enterprise, Sunrise Pharmacy, Sunrise
Clinical Analytics and Sunrise Patient Portal are either registered
trademarks or trademarks of Eclipsys Corporation (or its
subsidiaries) in the United States and certain other countries.
Other product and company names in this news release are or may be
trademarks of their respective companies.
Eclipsys Corp. (MM) (NASDAQ:ECLP)
過去 株価チャート
から 10 2024 まで 11 2024
Eclipsys Corp. (MM) (NASDAQ:ECLP)
過去 株価チャート
から 11 2023 まで 11 2024
